arrow
T

Tuan Zea Tan

National University of Singapore
H指数:53
被引数:9,609

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Driver genomic lesions in MDM2, CDK4, and JUN co-opt targetable super-enhancer networks to impose liposarcomagenic core regulatory circuitry

MDM2、CDK4和JUN驱动基因突变利用可靶向的超级增强子网络构建脂肪肉瘤生成核心调控回路

2026-08-310
OAAI
Spatial transcriptomic profiling of ovarian clear cell carcinoma reveals heterogeneity in OXPHOS and EMT gradients

卵巢透明细胞癌的空间转录组学分析揭示了OXPHOS和EMT梯度中的异质性

2026-07-080
OAAI
DP103 as a critical modulator of Wnt signaling and cancer stemness: implications for precision treatment in triple negative breast cancer

DP103作为Wnt信号通路和癌症干细胞的关键调控因子:对三阴性乳腺癌精准治疗的启示

2026-06-050
OAAI
Mitochondrial translocation of MDM2 and TFAM reprograms metabolism in treatment-refractory cancers

线粒体中MDM2和TFAM的转位在治疗难治性癌症中重编程代谢

2026-04-160
OAAI
Accelerated ageing predicts earlier onset of ischaemic stroke: a proteomic and transcriptomic investigation

加速老化预测缺血性卒中的更早发病:一项蛋白质组学和转录组学研究

2025-11-010
PRE
A phase 1b, multicentre, dose escalation, safety and pharmacokinetics study of tilvestamab (BGB149) in relapsed, platinum-resistant, high-grade serous ovarian cancer (PROC) patients

一项关于tilvestamab(BGB149)在复发、铂耐药、高级别浆液性卵巢癌(PROC)患者中的1b期、多中心、剂量递增、安全性和药代动力学研究

2025-07-220
OAAI
A multi-task domain-adapted model to predict chemotherapy response from mutations in recurrently altered cancer genes

一个多任务领域自适应模型,用于预测从复发性改变的癌基因突变中化疗反应

2025-02-010
OAAI
Comprehensive characterization of genomic features and clinical outcomes following targeted therapy and secondary cytoreductive surgery in OCCC: a single center experience
2024-01-012
OAAI